Masthead-Image-Right-min

Navigating Reimbursement for Liquid Biopsy Cancer Testing

Thirty-eight percent of private payers now cover some type of ctDNA-based panel testing. Is your lab aware of evolving payment policies?

Continue Reading...

COVID-19: Insurers Exempt from Covering Workplace Testing

Must Cover “Medically Appropriate” Tests Only

Continue Reading...

Protect Revenue Cycle Capabilities to Limit COVID-19 Fallout

Hospitals must be aware of operational issues that could negatively impact cash flow.

Continue Reading...

How to Receive Reimbursement for Uninsured COVID-19 Patients

Legislation enacted providing reimbursement for testing and treatment of uninsured COVID-19 patients.

Continue Reading...

Key Takeaways from the 2019 CAQH Index

The CAQH Index addresses how reducing the burdens of administrative costs could reduce healthcare spending.

Continue Reading...